TABLE 1.
Distribution of clinical characteristics among two immune subtypes in three datasets.
| Subtype 1 | Subtype 2 | p-value | |
|---|---|---|---|
| (n = 361) | (n = 209) | ||
| Dataset | 0.000 | ||
| GSE16446 | 55(0.15) | 52(0.25) | |
| GSE103091 | 187(0.51) | 51(0.24) | |
| GSE20685 | 119(0.33) | 106(0.51) | |
| Age | 0.895 | ||
| (26,46) | 70(0.41) | 62(0.41) | |
| (46,55) | 41(0.24) | 32(0.21) | |
| (55,64) | 30(0.18) | 30(0.20) | |
| (64,90) | 30(0.18) | 24(0.16) | |
| Grade | 0.452 | ||
| Grade1 | 2(0.04) | (0) | |
| Grade2 | 10(0.18) | 9(0.17) | |
| Grade3 | 38(0.69) | 43(0.83) | |
| Primary tumor (T) | 0.114 | ||
| T1 | 34(0.20) | 42(0.26) | |
| T2 | 118(0.69) | 92(0.58) | |
| T3 | 8(0.05) | 15(0.09) | |
| T4 | 10(0.06) | 11(0.07) | |
| Regional lymph nodes (N) | 0.997 | ||
| N0 | 72(0.42) | 66(0.41) | |
| N1 | 62(0.36) | 59(0.37) | |
| N2 | 23(0.13) | 22(0.14) | |
| N3 | 14(0.08) | 14(0.09) | |
| Metastasis | 0.999 | ||
| Non-metastasis | 117(0.67) | 123(0.67) | |
| metastasis | 58(0.33) | 61(0.33) | |
| Status | 0.562 | ||
| Alive | 82(0.76) | 167(0.78) | |
| Dead | 26(0.24) | 45(0.21) |